Fact-checked by Grok 2 weeks ago

Kary Mullis

Kary Banks Mullis (December 28, 1944 – August 7, 2019) was an American biochemist best known for inventing the (), a technique that allows for the exponential amplification of specific DNA segments from minute quantities, fundamentally transforming , diagnostics, and . While working at , Mullis conceived the method in 1983 during a drive along 17, initially sketching the concept on a roadside notepad; the process, which cycles DNA through denaturation, annealing, and extension phases using a thermostable , was first demonstrated in 1985 and patented in 1987. For this innovation, which enables replicating millions of copies of a DNA sequence in a , Mullis shared the 1993 with , whose complemented 's applications in . Mullis's career included a Ph.D. in biochemistry from the , and roles in industry where he synthesized before 's development. Beyond his scientific contributions, Mullis was a vocal skeptic of positions, questioning the direct causal linking to AIDS—famously asking for the specific paper proving it—and expressing doubts about human-driven while showing interest in and paranormal phenomena, views that drew criticism from mainstream scientific institutions despite his empirical success in .

Early Life and Education

Upbringing in North Carolina

Kary Banks Mullis was born on December 28, 1944, in , a town in Caldwell County situated in the foothills of the . He was the second of four sons born to Cecil Banks Mullis, who worked in sales, and Bernice Alberta Barker Mullis, who initially stayed at home before later becoming a realtor. Both parents had themselves grown up in rural settings, with Mullis's paternal family involved in small-scale manufacturing ventures, including wartime contracts for aluminum products during . The Mullis family resided in a rural environment that fostered an early affinity for hands-on exploration and natural observation. From a young age, Mullis displayed curiosity about the natural world, spending time watching animals, , and conducting informal experiments with available materials in the countryside. This period, though brief before the family's relocation, laid foundational interests in and scientific , as Mullis later recalled tinkering with homemade setups amid the rural landscape. In 1949, at the age of five, the family moved to , where Mullis's father continued in sales, shifting the household's primary base away from . His North Carolina upbringing, thus limited to early childhood, nonetheless influenced his independent, inquisitive approach to problem-solving that characterized his later scientific career.

Academic Training and Degrees

Mullis received a degree in chemistry from the Georgia Institute of Technology in in 1966. During his undergraduate years, he studied chemistry and physics while contributing fiction to the campus humor magazine. He pursued doctoral studies in biochemistry at the , starting in 1966, and earned his Ph.D. in 1972 under the supervision of J.B. Neilands. Following completion of his doctorate, Mullis lectured in biochemistry at until 1973. Subsequently, he undertook postdoctoral fellowships in pediatric cardiology at the University of Kansas Medical Center from 1973 to 1977, focusing on pharmaceutical aspects of heart disease.

Professional Career

Early Positions in Chemistry and Biochemistry

Following his Ph.D. in biochemistry from the University of California, Berkeley in 1972, Mullis completed a postdoctoral fellowship at the University of Kansas, where he investigated the structure and function of immunoglobulins under Russell Montgomery. He then pursued another postdoctoral position at the University of California, San Francisco (UCSF), focusing on nucleic acid/protein interactions with David Freifelder. Subsequently, Mullis joined in , working for a small pharmaceutical division where he gained experience in drug synthesis. After one year in that role, he returned to UCSF's for an additional year of pharmaceutical research. In 1979, Mullis accepted a position as a DNA chemist at , a firm in , despite limited prior experience in . Over the next several years at , he advanced to head the laboratory, contributing to early production efforts amid the emerging sector.

Invention and Development of PCR

Kary Mullis conceived the polymerase chain reaction (PCR) technique in 1983 while driving along a winding mountain road in California, envisioning a method to exponentially amplify specific DNA segments through repeated cycles of denaturation, primer annealing, and polymerase-mediated extension. At the time, Mullis was employed as a DNA chemist at Cetus Corporation, a biotechnology firm in Emeryville, California, where he worked on projects involving oligonucleotide synthesis and genetic analysis challenges, such as detecting rare mutations in human genes. The core innovation of PCR addressed limitations in prior DNA cloning methods, which relied on bacterial propagation and were inefficient for small or specific sequences; instead, PCR enabled in vitro amplification using short synthetic primers flanking the target region, thermostable conditions for strand separation, and a DNA polymerase to synthesize complementary strands in a chain reaction that doubles the DNA quantity each cycle. Early proof-of-concept experiments in 1983–1984 at used the of , requiring manual intervention to replenish the enzyme after each denaturation step due to its heat lability, thus limiting throughput to a few cycles per run. A pivotal advancement came with the adoption of Taq DNA polymerase, isolated from the thermophilic bacterium , which Cetus researchers, including Mullis, began utilizing around 1985; this enzyme's thermostability eliminated the need for repeated enzyme additions, enabling automated thermal cycling in a single tube and scaling amplification to millions of copies. The first published application of PCR appeared in 1985, demonstrating its utility in amplifying human beta-globin sequences for diagnosing sickle cell anemia via restriction fragment analysis, marking the technique's transition from concept to practical tool. By 1986, Mullis and colleagues formalized the method in a seminal paper describing the process, solidifying its foundational role in .

Commercialization of PCR and Later Work

In 1986, Mullis departed Cetus Corporation, having received a $10,000 bonus for the invention, though the company retained ownership of the . 's commercial potential grew through applications in diagnostics and research, leading Cetus to partner with Hoffmann-La Roche in 1989 for development of -based tests. On July 23, 1991, Cetus finalized the sale of its technology and patents to Hoffmann-La Roche for $300 million upfront plus royalties, enabling widespread commercialization of kits and enabling technologies like automated thermal cyclers. This transaction generated substantial royalties for Cetus and its stakeholders, including Mullis as the inventor, transforming into a foundational tool in with annual revenues exceeding hundreds of millions by the mid-1990s. Following his time at , Mullis served as director of at Xytronyx, Inc., from 1986 to 1988, focusing on biotech applications. Thereafter, he operated as a freelance consultant for various firms, applying and related techniques while pursuing independent research in and DNA analysis. In the ensuing years, Mullis held multiple patents beyond , including innovations in and diagnostic assays, contributing to advancements in . Mullis founded Altermune Technologies to develop chemically programmable immunity strategies, serving as its chief scientific officer and president, with a focus on "alphamers"—synthetic molecules designed to modulate immune responses against allergens and pathogens. The company's work targeted novel therapies for infectious diseases and hypersensitivity, patenting alphamer technology assigned to Altermune, which later evolved into Centauri Therapeutics emphasizing immune reprogramming. This venture represented Mullis's shift toward therapeutic immunology, building on PCR's enabling role in genomic research but independent of its core commercialization.

Scientific Recognition

Nobel Prize in Chemistry

In 1993, Kary B. Mullis received one half of the Nobel Prize in Chemistry for his invention of the polymerase chain reaction (PCR), a method enabling the rapid amplification of specific DNA segments from minute samples. The other half was awarded to Michael Smith for developing oligonucleotide-based, site-directed mutagenesis, a technique for precise genetic alterations in DNA. The Nobel Committee highlighted PCR's transformative impact on DNA-based chemistry, facilitating advancements in genetic analysis, diagnostics, and biotechnology by allowing exponential DNA replication in vitro without reliance on living organisms. The award was announced on October 13, 1993, recognizing Mullis's work conducted at , where the initial experiments succeeded in December 1984 using from . Mullis's contribution stemmed from a conceptual breakthrough in 1983, envisioning repeated cycles of DNA denaturation, primer annealing, and polymerase extension to achieve amplification. This innovation, detailed in his Nobel Lecture delivered on December 8, 1993, titled "The ," underscored the method's simplicity and universality, originating from an idea that crystallized during a nighttime drive along Highway 101. The Nobel Foundation's recognition affirmed PCR's foundational role in molecular biology, enabling applications from forensic DNA profiling to genomic sequencing, though Mullis later expressed reservations about certain extrapolations of the technique beyond its validated limits. At the time of the award, Mullis was affiliated with Cetus, which had patented PCR in 1987, licensing it to Hoffman-La Roche for $300 million in 1991, underscoring the method's commercial viability.

Other Awards and Patents

In addition to the Nobel Prize, Mullis received the William Allan Memorial from the American Society of Human Genetics in 1990 for contributions to through development. He was awarded the Gairdner Foundation International in 1991 for advancing medical via . In 1992, Mullis earned the Robert Koch Prize for biomedical research achievements and the California Scientist of the Year from the California Teachers . The following year, he received the Japan Prize from the and Technology Foundation of Japan, valued at approximately $450,000, specifically for the development of technology, which revolutionized gene analysis. Also in 1993, Mullis obtained the Thomas A. Edison from the American Society for Biochemistry and Molecular Biology for innovative scientific contributions. Mullis held numerous patents related to nucleic acid amplification and detection, primarily stemming from his work at Cetus Corporation. Key examples include U.S. Patent 4,683,195 (issued July 28, 1987), covering processes for amplifying, detecting, and cloning nucleic acid sequences using PCR, and U.S. Patent 4,683,202 (issued July 28, 1987), detailing the amplification of target nucleic acid sequences with thermostable enzymes. These foundational patents, co-invented with colleagues like Randall K. Saiki and Henry A. Erlich, expired in the early 2000s but generated significant royalties for Cetus before its acquisition by Hoffmann-La Roche in 1991. Mullis also patented variations, such as methods for detecting specific nucleic acid sequences (U.S. Patent 4,965,188, issued October 23, 1990), and later inventions including a UV-sensitive plastic that changes color under light exposure. In total, he is listed as an inventor on over 20 U.S. patents, many focused on PCR applications in diagnostics and forensics.

Heterodox Views on Established Science

Challenge to HIV as Cause of AIDS

Kary Mullis voiced persistent skepticism toward the prevailing hypothesis that the human immunodeficiency virus () directly causes acquired immunodeficiency syndrome (AIDS), arguing that the evidence failed to meet rigorous standards of causation. While developing a PCR-based test for detection in the late , Mullis reportedly searched for a single paper demonstrating HIV's causal role but found none, later recounting in interviews his frustration: "What is that paper? Who do I go to for that?" He contended that between HIV positivity and AIDS diagnoses did not equate to proof, as most AIDS patients exhibited numerous opportunistic infections and comorbidities regardless of viral status. In a 1993 Nobel Prize interview, Mullis rejected the idea of HIV as a singular retroviral culprit, describing it as a "pseudo-species" with rapidly mutating sequences and proposing instead that AIDS symptoms arose from an overwhelming burden of viruses across the Retroviridae family, eroding immune function through cumulative effects rather than isolated infection. He criticized the AIDS research establishment for fixating on HIV for over a , attributing stalled progress to this narrow paradigm: "They’re only looking at this one species... and they’re not recognising the problem." Mullis aligned with Peter Duesberg, who invoked —criteria requiring pathogen isolation, reproduction of disease in hosts, and re-isolation—to argue HIV failed as a causal agent, noting inconsistencies such as HIV-positive individuals remaining for years and AIDS-like conditions in non-HIV contexts among high-risk groups like drug users and hemophiliacs. Mullis further challenged the misuse of PCR in HIV diagnostics, emphasizing that the technique, which he invented for amplifying DNA segments, was not designed for absolute quantification of infectious particles or . In his 1998 autobiography Dancing Naked in the , he asserted that " does not cause AIDS," framing the narrative as driven by institutional incentives rather than empirical validation, and warned against conflating PCR-detected genetic fragments with viable, pathogenic . His position, echoed in public forums, highlighted alternative factors in AIDS —such as risks, recreational drugs, and in affected populations—while questioning why models failed to reliably induce AIDS via . These views positioned Mullis among a minority of scientists dissenting from the consensus, drawing criticism for potentially undermining efforts, though he maintained they stemmed from first-principles scrutiny of unproven assumptions in . By the time of his in , Mullis's critiques had influenced AIDS denialist circles but lacked broad empirical support within , which relied on antiretroviral and epidemiological data to affirm HIV's role.

Skepticism Toward Anthropogenic Climate Change

Kary Mullis expressed skepticism toward the attribution of recent climate variations primarily to human CO2 emissions, emphasizing insufficient understanding of natural climate variability over geological timescales. In a , he highlighted that during the Eocene epoch, approximately 34 to 56 million years ago, atmospheric CO2 concentrations were several times higher than the roughly 400 ppm recorded in the late , yet global temperatures supported diverse life forms from pole to pole without evidence of catastrophe. He argued that the Earth's climate had fluctuated radically over the prior 40 million years, through eras like the , , and , each with distinct , , and conditions independent of human activity. Mullis contended that without explaining these historical transitions, scientists lacked the foundation to predict future changes or confidently implicate factors, dismissing such claims as "worse than audacious" and "pathetic." He viewed the prevailing emphasis on human causation as politically motivated rather than empirically driven, prioritizing models over verifiable causation. In a 1994 interview, Mullis described alarms, alongside concerns, as overhyped issues that would ultimately prove to be nonproblems, rooted in environmental rather than rigorous evidence. In his 1998 autobiography Dancing Naked in the Mind Field, Mullis further critiqued the narrative, writing that "global warmers predict that is coming, and our emissions are to blame" to maintain public worry and secure research funding, accusing skeptics of being labeled "misguided" to suppress doubt. He portrayed the as a product of institutional incentives, including grant-seeking, rather than falsifiable , echoing his broader distrust of dogmatic claims in fields like . A 1998 profile quoted him dismissing evidence as "blatant balderdash, a fiction concocted by pseudo-scientists," linking it to systemic in peer-reviewed research. Mullis's position aligned with his insistence on direct experimental proof over correlative models, though it drew from mainstream climatologists who cited post-1990s on and isotopic signatures supporting human influence.

Critiques of Scientific Dogma and PCR Misuse

Mullis frequently challenged what he perceived as rigid adherence to , arguing that it stifled inquiry and prioritized authority over . In his 1998 Dancing Naked in the Mind Field, he compared public trust in scientists' proclamations to the once reserved for , asserting that such deference often accepts unproven claims without scrutiny. He specifically contested established narratives, including the causal role of in AIDS, anthropogenic contributions to , and the link between chlorofluorocarbons and , describing them as beliefs propped up by institutional momentum rather than falsifiable data. Mullis advocated for driven by individual and empirical testing, warning that could devolve into when dissenting is marginalized, as seen in the of researchers questioning dominant paradigms. Central to his concerns was the potential misuse of PCR technology, which he invented for amplifying specific DNA segments but cautioned was not inherently quantitative or diagnostic for infectious agents. Mullis emphasized that PCR's sensitivity enables detection of trace genetic material—potentially from non-viable fragments or contaminants—without indicating active replication or clinical relevance. In a 1997 discussion on HIV testing, he stated, "Anyone whose DNA is not precisely identical to the [target] DNA can't be positively identified as having any sort of disease... With PCR, if you do it well, you can find almost anything in anybody," underscoring how high amplification cycles (e.g., above 35-40) could yield misleading positives by amplifying irrelevant sequences. He applied this critique to viral load measurements, arguing that PCR-derived counts of HIV RNA failed to correlate reliably with disease progression or prove causation, as the method does not distinguish infectious virions from inert nucleic acids. These positions drew sharp rebukes from institutions, which Mullis attributed to a favoring orthodoxy over rigorous validation—a pattern he observed in fields reliant on funding and peer approval rather than reproducible causation. Despite PCR's Nobel-recognized utility in , Mullis maintained it required contextual alongside clinical symptoms and methods to avoid , a rooted in first-principles assessment of amplification artifacts over blind reliance on cycle threshold outputs.

Personal Influences and Beliefs

Use of LSD and Psychedelics

Kary Mullis began experimenting with lysergic acid diethylamide (LSD) in 1966 while studying at the University of California, Berkeley, where he ingested a 1000 microgram dose under the guidance of a friend, describing the experience as inducing a loss of time continuity, heightened sense of freedom, and profound appreciation for existence that lasted approximately four hours. He characterized it as "the most incredible thing I’ve ever done," noting that it had irrevocably altered his perspective despite prior warnings from family about its risks. This initial encounter, legal at the time amid broader cultural experimentation tied to anti-war movements, sparked Mullis's interest in neurochemistry and mind-altering substances, leading him to synthesize other psychedelics such as diethyltryptamine, which once resulted in a severe overdose causing temporary ego dissolution. He also explored compounds like methylenedioxyamphetamine (MDA), praising its effects of inducing warmth and euphoria for around eight hours. Mullis continued psychedelic use into his graduate years, incorporating psychoactive drugs that he credited with expanding his cosmic understanding and informing early publications, such as a 1968 article in Nature. He later attributed the creative leap enabling his 1983 invention of the polymerase chain reaction (PCR) to prior LSD experiences, asserting in a 1994 interview that they fostered an ability to conceptualize molecular dynamics unconventionally: "Would I have invented PCR if I hadn't taken LSD? I seriously doubt it. I learnt that partly on psychedelic drugs. I could sit on a DNA molecule and watch the polymers go by and see that they’re all too small." Mullis maintained that such substances disrupted rigid linear thinking, allowing insights unattainable through conventional scientific training, though he clarified the PCR epiphany occurred during a routine drive rather than under acute intoxication. Admissions of his LSD use drew scrutiny during professional engagements, including preparations for his testimony in the 1995 O.J. Simpson trial, where prosecutors invoked it to impugn his reliability; Mullis countered by emphasizing that openly acknowledging illegal activity underscored his dedication to candor: "If I took my honesty seriously enough to admit that I had broken the law by taking , why would I lie about anything else?" In his 1998 autobiography Dancing Naked in the Mind Field, he reflected on psychedelics as tools for perceptual expansion rather than mere recreation, defending their role in personal growth amid concerns raised by Nobel evaluators about his unconventional lifestyle. Mullis's accounts portray not as a direct causal agent for but as a formative influence on his rejection of dogmatic approaches in science.

Interest in Paranormal Phenomena

Mullis professed a belief in astrology, which he defended publicly despite his scientific background. In interviews and his 1998 autobiography Dancing Naked in the Mind Field, he argued that astrological influences could align with empirical patterns in human behavior, though he acknowledged the lack of rigorous scientific validation for such claims. A notable personal experience occurred in 1985 when Mullis reported encountering a glowing during a late-night walk on his property in . He described the animal as luminous—possibly green—and addressing him courteously as "doctor" before an apparent lapse in memory, which he later recounted as a potential abduction-like event in his , though he did not conclusively attribute it to origins. Mullis also claimed to have been rescued from a near-fatal car accident by an entity traveling in an , an incident he cited as evidence of non-physical phenomena influencing physical events. These accounts, often linked to his experimentation with during the 1960s and 1970s, reflected his broader openness to unexplained experiences beyond conventional scientific explanation, as detailed in his writings and interviews.

Family Life and Lifestyle

Mullis was married four times. His first marriage was to Richards Haley, whom he wed while pursuing a B.S. in at the Georgia Institute of Technology; the union produced a daughter, , before ending in divorce. He later married Cynthia Gibson as his second wife, with whom he had two sons, Christopher and Jeremy. His third marriage was to Gail Hubbell, which also concluded in divorce. In 1997, Mullis married Nancy Cosgrove, his fourth wife, with whom he remained until his death in 2019, marking 22 years together. He maintained positive relations with his former spouses and described his three children—aged 12, 16, and 28 at the time of his 1993 Nobel acceptance—as integral to his life. At his passing, Mullis was survived by Nancy, his three children, and two grandchildren. Mullis resided primarily in , embracing a coastal lifestyle that included , and he also spent time in Anderson Valley, California. A proficient on guitar and as a vocalist, he pursued creative outlets alongside his scientific career, reflecting an eclectic personal routine centered on family, recreation, and intellectual pursuits.

Death and Enduring Legacy

Final Years and Passing

In the decade preceding his death, Kary Mullis resided in , with his wife, Nancy Cosgrove Mullis, to whom he had been married since 1998. He maintained involvement in through Altermune Technologies (later rebranded as Centauri Therapeutics), a company he co-founded to develop therapies targeting drug-resistant pathogens such as via modulation. Mullis died on August 7, 2019, at his home in Newport Beach at the age of 74. The immediate cause was complications from , which led to heart and . He was survived by his wife and three children from prior marriages.

PCR's Transformative Impact on Science

The (PCR), conceived by Kary Mullis in , enables the exponential amplification of targeted DNA sequences from minuscule starting amounts, typically through 20–40 thermal cycles of denaturation, primer annealing, and enzymatic extension using thermostable such as Taq. This method, which Mullis developed while employed at , overcame prior limitations in DNA manipulation by automating replication without the need for bacterial cloning vectors, yielding billions of copies in hours rather than days or weeks. For this innovation, Mullis shared the with , with the Nobel Committee highlighting PCR's role in "decisive progress in gene technology." In and , PCR catalyzed foundational advances, including efficient gene cloning, , and the study of , which were instrumental to the completed in 2003 and the ensuing era of high-throughput . It facilitated the isolation and analysis of specific genetic loci, enabling breakthroughs in understanding hereditary diseases, evolutionary relationships, and protein-DNA interactions that were previously intractable due to sample scarcity. Variants like quantitative real-time PCR (qPCR) further expanded its utility, allowing precise measurement of DNA or RNA levels in real time, which underpins and epigenetic research. PCR's diagnostic applications transformed clinical medicine by permitting rapid detection of pathogens from low-biomass samples, such as identifying bacterial or viral infections via amplification of signature nucleic acids, often within hours. In forensics, it revolutionized by amplifying trace evidence—like a single hair or skin cell—from crime scenes, enabling that matches individuals with probabilities exceeding 1 in a trillion, thus exonerating the innocent and convicting perpetrators in thousands of cases since the late . Beyond these, PCR supports paternity testing, recovery in (e.g., sequencing), and agricultural for crop improvement, collectively fueling the industry's growth to a multi-billion-dollar sector by the .

Posthumous Relevance and Debates

Following Mullis's death on August 7, 2019, his pre-existing critiques of 's application gained significant traction during the , as skeptics cited his warnings against using the technique as a standalone diagnostic for infectious diseases. Mullis had emphasized that amplifies genetic fragments and, at high cycle thresholds ( values often exceeding 35-40), could detect non-infectious remnants rather than active , potentially inflating case counts. For instance, he stated in a 1997 documentary interview: "With , if you do it well, you can find almost anything in anybody," highlighting its but limitations in distinguishing viable pathogens from trace nucleic acids. This perspective was invoked by critics of mass screening policies, who argued it contributed to overcounting infections, though authorities maintained that validated protocols, including cutoffs and clinical correlation, ensured reliability. His longstanding skepticism regarding as the sole cause of AIDS also persisted posthumously, referenced in dissident literature challenging the despite overwhelming empirical evidence from longitudinal studies linking seropositivity to decline and opportunistic infections. In a 2005 Nobel Foundation , Mullis questioned the retroviral causation model, asserting no existed tying to AIDS-defining conditions and advocating for explanations like drug use or immune dysregulation. Such views, echoed in works like the 2014 review "Questioning the HIV-AIDS Hypothesis," fueled ongoing debates but were dismissed by mainstream , which cites over 30 years of data from antiretroviral trials showing suppression prevents progression to AIDS. Mullis's position, while highlighting early correlation gaps, overlooked causal mechanisms like into host genomes, as demonstrated in models and studies. Broader posthumous discussions framed Mullis as an "intolerable genius," lauding PCR's revolutionary impact on —enabling everything from vaccine development to forensic —while critiquing his dismissals of anthropogenic and endorsement of pseudoscientific ideas like . Obituaries and analyses post-2019, such as in California Magazine, debated reconciling his inventive brilliance with contrarian stances that alienated peers, attributing them to his self-described intuitive, non-dogmatic approach rather than institutional bias. These debates underscored tensions in scientific discourse, where empirical validation trumps outlier opinions, yet Mullis's legacy prompted reflections on PCR's dual role: a tool for truth-seeking discovery versus potential misuse in amplifying uncertainty without contextual safeguards.

References

  1. [1]
    Kary B. Mullis – Facts - NobelPrize.org
    Kary Mullis invented the process known as polymerase chain reaction (PCR), in which a small amount of DNA can be copied in large quantities over a short period ...
  2. [2]
    Kary Mullis dies at age 74 - C&EN
    Aug 21, 2019 · Kary B. Mullis, Nobel Laureate in Chemistry, died Aug. 7 of pneumonia at the age of 74. He won the 1993 Nobel Prize in Chemistry for his invention of the ...
  3. [3]
    Press release: The 1993 Nobel Prize in Chemistry - NobelPrize.org
    With PCR it is possible to replicate several million times, in a test tube, an individual DNA segment of a complicated genetic material. Mullis has described ...
  4. [4]
    The Discovery of PCR: ProCuRement of Divine Power - PMC - NIH
    The origins of PCR are usually attributed to Kary Mullis, a technician at the Cetus Corporation, assigned to improve the synthesis of oligonucleotides. He ...
  5. [5]
    Kary B. Mullis – Biographical - NobelPrize.org
    She provided medical care to livestock, for which she had been trained, but also to people for whom she was the only alternative on her side of the Catawba ...
  6. [6]
    Kary B. Mullis – Interview - NobelPrize.org
    May I ask if your research would have any implication on the race that we have now for finding some kind of vaccine for the HIV and AIDS epidemic? Kary B.Missing: controversies | Show results with:controversies
  7. [7]
    Fact check: Abundant scientific research shows HIV causes AIDS
    Jan 6, 2023 · A narrator says Mullis found no proof when he searched for evidence HIV caused AIDS. “What is that paper? Who do I go to for that?” Mullis says.
  8. [8]
    Intolerable Genius: Berkeley's Most Controversial Nobel Laureate
    Dec 12, 2019 · President Thabo Mbeki, under the spell of AIDS denialists including Mullis, declared that AIDS was caused by poverty, not HIV. Many South ...
  9. [9]
    Biography - Dr. Kary Banks Mullis
    He moved to Columbia, South Carolina at the age of five, attending A.C. Moore Elementary School, Hand Junior High School, and graduating from Dreher High School ...Missing: upbringing childhood facts
  10. [10]
    Kary Mullis, a Newport resident and quirky Nobel laureate whose ...
    Aug 14, 2019 · The family moved to Columbia, S.C., when Mullis was a child. He showed a keen interest in science and exploration at a young age.Missing: upbringing North Carolina facts
  11. [11]
    Kary Mullis and the Invention of PCR - BioPathogenix
    Feb 17, 2025 · In December 1985, Kary Mullis and Randy Saiki published the first scientific paper on PCR, demonstrating its ability to amplify β-globin ...
  12. [12]
    Mullis, Kary Banks - South Carolina Encyclopedia
    When he was five years old, Mullis and his family moved to Columbia, South Carolina, where his father worked as a furniture salesman and his mother, after a ...Missing: upbringing facts
  13. [13]
    CV - Kary Mullis - Lindau Mediatheque
    Kary Banks Mullis, Nobel Prize winning chemist, was born on December 28 ... Kary Banks Mullis passed away on 7 August 2019, at the age of 74. Copied to ...
  14. [14]
    Dr. Kary Banks Mullis - First Day Covers from the Collection of ...
    May 8, 2025 · Kary Banks Mullis, Nobel Prize winning chemist, was born on December 28, 1944, in Lenoir, North Carolina. · He received a Bachelor of Science ...Missing: upbringing childhood facts<|separator|>
  15. [15]
    2004 World Congress Keynote Speaker: Kary Banks Mullis
    Dr. Mullis received a Bachelor of Science degree in chemistry from the Georgia Institute of Technology in 1966, and went on to earn a PhD in biochemistry from ...Missing: background | Show results with:background
  16. [16]
    Nobel Prize Winning Emeryville Scientist Kary Mullis Passes at 74
    Aug 11, 2019 · ... Berkeley and Richmond. Mullis received his doctorate in biochemistry from UC Berkeley in 1973. After completing postdoctoral fellowships at ...Missing: PhD | Show results with:PhD<|separator|>
  17. [17]
    Kary B. Mullis | myadlm.org
    I invented the polymerase chain reaction (PCR). It was the first day of the rest of my life. Things happened slowly at first but with an accelerating pace. I ...
  18. [18]
    Kary B. Mullis – Nobel Lecture - NobelPrize.org
    I published my first scientific paper in Nature, in 1968. It was a sophomoric astrophysical hypothesis called “The Cosmological Significance of Time Reversal.” ...
  19. [19]
    PCR Technology: Key Milestones in Development and Maturation - US
    In 1983, Kary Mullis, a biochemist at Cetus Corporation, invented PCR. His vision was to use a cyclical process of heating and cooling to denature DNA, anneal ...<|separator|>
  20. [20]
    The History of PCR | Thermo Fisher Scientific - US
    Taq enzyme's impact on molecular biology became apparent in 1988 when Kary Mullis and the Cetus Corporation commercialized the enzyme for widespread use.
  21. [21]
    Specific enzymatic amplification of DNA in vitro - PubMed
    Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. ... K Mullis, F Faloona, S Scharf, R Saiki, G Horn, H Erlich. PMID: 3472723; DOI ...
  22. [22]
    History of the Polymerase Chain Reaction Videohistory Collection ...
    Kary Mullis invented the PCR technique in 1985 while working as a chemist at the Cetus Corporation, a biotechnology firm in Emeryville, California. The ...
  23. [23]
    2 Biotech Pioneers To Merge - The New York Times
    Jul 23, 1991 · In a related move, Hoffmann-La Roche said it would pay $300 million plus royalties to acquire Cetus's coveted polymerase chain reaction ...Missing: date | Show results with:date
  24. [24]
    Biotech Pioneer Cetus, Neighbor Firm to Merge - Los Angeles Times
    Jul 23, 1991 · Cetus also said it would sell its polymerase chain reaction technology research section to Hoffmann-La Roche for $300 million plus royalties of ...
  25. [25]
    The polymerase chain reaction patents: going, going,... still going - NIH
    Kary Mullis was awarded the Nobel Prize in Chemistry in 1993 for inventing ... royalties. The uses and variants of polymerase chain reaction have grown ...
  26. [26]
    Kary B. Mullis | Research Starters - EBSCO
    Born: December 28, 1944 · Birthplace: Lenoir, North Carolina · Died: August 7, 2019 · Place of death: Newport Beach, CA.
  27. [27]
    [PDF] ALTERMUNE'S ALPHAMERS - UCSD Department of Pediatrics
    May 28, 2015 · Loxbridge was also a founding investor in Altermune. The alphamer technology was patented by Mullis and the patent was assigned to Altermune.<|control11|><|separator|>
  28. [28]
    https://www.invent.org/inductees/kary-b-mullis
  29. [29]
    The Nobel Prize in Chemistry 1993 - NobelPrize.org
    The Nobel Prize in Chemistry 1993 was awarded for contributions to the developments of methods within DNA-based chemistry jointly with one half to Kary B. ...
  30. [30]
    Dr. Kary Mullis - A Superstar of Science
    Mullis received William Allan Memorial Award of the American Society of Human Genetics 1990, Gairdner Award 1991 Thomas A. Edison Award 1993 and California ...<|separator|>
  31. [31]
    The 1993 Japan Prize
    Mullis' achievement, the Development of the polymerase Chain Reaction, has brought a revolution in the technology for analyzing genes, and is a great monumental ...
  32. [32]
    Is Kary Mullis God? (or Just the Big Kahuna?) - Esquire
    Jan 9, 2025 · While pursuing a degree in biochemistry, Mullis experimented with his own biology—discovering a new sexual freedom. “It wasn't a good place to ...
  33. [33]
    US4683195A - Process for amplifying, detecting, and/or-cloning ...
    The patent describes the synthesis and cloning of the somatostatin gene. A second type of organic synthesis is the phosphodiester method, which has been ...
  34. [34]
    US4683202A - Process for amplifying nucleic acid sequences
    The patent describes the synthesis and cloning of the somatostatin gene. A second type of organic synthesis is the phosphodiester method, which has been ...
  35. [35]
    Kary B. Mullis Inventions, Patents and Patent Applications
    Kary B. Mullis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that ...
  36. [36]
    Kary Mullis Inventions, Patents and Patent Applications
    Kary Mullis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that ...
  37. [37]
    Think Out of the Box, Think Out of the Eye Reappraisal of HIV/AIDS ...
    They were supported by Kary Mullis ... In particular, Duesberg argued that HIV did not fulfill Koch's postulates for identifying the causes of infectious diseases ...
  38. [38]
    DANCING NAKED IN THE MIND FIELD - Kirkus Reviews
    7-day returnsBut what really irks is when Mullis pontificates on other aspects of science. HIV does not cause AIDS, he says; we've been fed a bill of goods by greedy ...
  39. [39]
    Questioning the HIV-AIDS Hypothesis: 30 Years of Dissent - PMC
    Kary Mullis … is thoroughly convinced that HIV is not the cause of AIDS. With regard to the viral-load tests, which attempt to use PCR for counting viruses ...
  40. [40]
    [PDF] AIDS and GLOBAL WARMING These issues are complex and not to ...
    These issues are complex and not to be resolved by a paragraph. Anyone truly interested in either should be willing to dig hard into the scientific ...Missing: interview nonproblem
  41. [41]
    [PDF] Dancing Naked in the Mind Field - AIDSTruth
    "Global warmers predict that global warming is coming, and our emissions are to blame. They do that to keep us worried about our role in the whole thing. If ...
  42. [42]
    NOBEL CHEMIST KARY MULLIS, MAKING WAVES AS A MIND ...
    Nov 3, 1998 · One result of scientific corruption is the evidence for global warming, he says. It's blatant balderdash, a fiction concocted by pseudo- ...
  43. [43]
    Climate misinformation by source: Kary Mullis - Skeptical Science
    "In the Eocene carbon dioxide levels were several times higher than they are currently." Climate has changed along with CO2 levels through geological time.
  44. [44]
    Dancing Naked in the Mind Field Quotes by Kary Mullis - Goodreads
    Dancing Naked in the Mind Field Quotes · The biggest battle I fought with the danger officer was over the fact that I insisted on keeping my lunch and a case of ...
  45. [45]
    Fact check: Kary Mullis quote on PCR tests is outdated, lacks context
    Jan 14, 2022 · A quote from Nobel-winning chemist Kary Mullis about PCR testing was made in the 1990s and is unrelated to COVID-19.
  46. [46]
    PCR inventor Kary Mullis quote doesn't prove the tests are useless
    Jan 27, 2022 · When asked about using PCR to detect the HIV virus he said: “And with PCR, if you do it well, you can find almost anything in anybody.” PCR ...Missing: Koch postulates<|separator|>
  47. [47]
    Are PCR tests the best way to track Covid? | The Spectator
    Jun 19, 2021 · ... Some of this criticism has centred around alleged quotes from Kary Mullis, the Nobel Prize-winner chemist who invented the PCR test in.
  48. [48]
    [PDF] Dancing Naked in the Mind Field - Pearl HiFi
    “A very good book by a fascinating man.… [Mullis] enjoys an almost frighteningly brilliant mind and yet somehow manages to keep his feet firmly on the ...
  49. [49]
    LSD, DNA, PCR: The Strange Origins Of A Biology Revolution
    Mar 30, 2022 · I learnt that partly on psychedelic drugs.” Albert Hoffman, who discovered LSD, has said that Mullis personally told him that the ...Missing: influence | Show results with:influence
  50. [50]
    The Beckley Foundation Intends To Study Links Between ... - Forbes
    Feb 26, 2018 · ... Would I have invented PCR if I hadn't taken LSD? I seriously doubt it,” he has said. “I could sit on a DNA molecule and watch the polymers ...
  51. [51]
    Dancing Naked in the Mind Field: Mullis, Kary - Books - Amazon.com
    Mullis writes with passion and humor about a wide range of topics: from global warming to the O. J. Simpson trial, from poisonous spiders to HIV, from ...
  52. [52]
    Weird Science - The New York Times
    Oct 11, 1998 · ''Dancing Naked in the Mind Field'' is a dumb title, perhaps, but this is a darkly joyous work, an autobiography of the nervous system of an ...
  53. [53]
    Scientist at Work/Kary Mullis; After the 'Eureka,' a Nobelist Drops Out
    Sep 15, 1998 · Interview with Dr Kary Mullis, who won Nobel Prize in chemistry for devising polymerase chain reaction that amplifies DNA and has become ...
  54. [54]
    The Man Who Photocopied DNA and Also Saw a Talking ...
    Aug 15, 2019 · Kary Mullis shared the Nobel Prize in Chemistry in 1993 for his discovery of an elegant technique to amplify parts of the DNA molecule.<|separator|>
  55. [55]
    Kary Mullis, quirky Nobel laureate whose DNA discovery changed ...
    Aug 13, 2019 · Acclaimed as his technique was, Mullis was highly criticized for other theories, notably his suggestion that HIV did not cause AIDS, which he ...
  56. [56]
    Kary B. Mullis, 74, Dies; Found a Way to Analyze DNA and Won Nobel
    Aug 15, 2019 · He earned his Ph.D. in biochemistry from the University of California, Berkeley, in 1972. Advertisement.
  57. [57]
    Nobel Laureate, Kary Mullis, dies age 74 - BioTechniques
    Aug 16, 2019 · It seems to go faster and faster” (Mullis, 1994). Mullis leaves behind a wife, Nancy, three children and two grandchildren. Source. https ...Missing: family | Show results with:family
  58. [58]
    [PDF] Kary Mullis Interview
    Denver would have escaped the tidal wave, but the world was totally changed in a matter of minutes. We can prevent this from happening if we put enough ...Missing: climate | Show results with:climate
  59. [59]
    PCR inventor Kary Mullis dies aged 74 | News - Chemistry World
    Aug 13, 2019 · Mullis was born in 1944 in rural North Carolina in the US. During high school, he developed an interest in science, and went on to study ...Missing: early life
  60. [60]
    Exponentially Important: The Scientific Origins of PCR
    Jul 28, 2021 · The invention of PCR in the 1980s was a scientific turning point with momentous consequences. Its discovery came on the heels of decades of advances in basic ...<|separator|>
  61. [61]
    Polymerase Chain Reaction (PCR) - StatPearls - NCBI Bookshelf - NIH
    Jul 7, 2025 · PCR is widely used in basic and biomedical sciences due to its high sensitivity, specificity, and rapid processing time, making it valuable in ...
  62. [62]
    PCR in Forensic Science: A Critical Review - PMC - NIH
    Mar 29, 2024 · This review examines the evolution of the PCR from its inception in the 1980s, through to its current application in forensic science.
  63. [63]
    PCR Applications—Top Seven Categories - Thermo Fisher Scientific
    PCR has a broad range of applications, not only in basic research but also in the areas of medical diagnostics, forensics, and agriculture.
  64. [64]
    Covid-19: Social murder, they wrote—elected, unaccountable, and ...
    Feb 4, 2021 · Any death, within 28 days of a positive PCR test (which Kary Mullis, the test's inventor, and Nobel Laureate was clear should not be used as ...Missing: misuse | Show results with:misuse